Arsenic and Environmental Health: State of the Science and Future Research Opportunities

1Inorganic and organic arsenic compounds continue to pose environmental public health challenges for hundreds of millions of people worldwide. Nearly every organ in the body can be affected by arsenic exposure, with health effects ranging from skin lesions and cancer to diabetes and lung disease. Given the ubiquitous nature of arsenic in the environment combined with growing evidence of health effects at lower levels of exposure to arsenic than previously thought, the prevention and mitigation of arsenic-induced adverse health outcomes requires more vigorous pursuit. A literature search of ongoing research related to arsenic in the environment resulted in > 1,000 papers published annually with “arsenic” in the title. From this voluminous wealth of information, the question becomes, what are the outstanding issues that would best drive future research directions?

2The National Institutes of Health’s National Institute of Environmental Health Sciences (NIEHS) Superfund Research Program (SRP) posed this question to leading arsenic researchers in remediation, exposure, and biomedical sciences. During March–June 2014, the NIEHS hosted a workshop and webinar series, “Health Effects and Mitigation of Arsenic: Current Research Efforts and Future Directions,” in Research Triangle Park, North Carolina. This workshop and webinar series provided forums to discuss state-of-the-science and knowledge gaps in arsenic research. This review is a discussion of highlights of cutting-edge research, data gaps, and suggestions for future research directions based on discussions at the workshop.

3A substantial amount of research has focused on exposure to arsenic via drinking water; however, more research is now being directed toward characterizing arsenic exposures from other sources. To develop a more complete understanding of arsenic exposure, more studies are needed to identify, quantify, and characterize arsenic in diet, soil, dust, and air. In addition, although much is known about some inorganic and organic forms of arsenic, data gaps in understanding exposures and toxicokinetics of other arsenic species (e.g., arsenoproteins, arsenolipids, and thiolated arsenic compounds) need to be addressed.

4Understanding arsenic speciation. Arsenic exists in many different inorganic and organic forms, and in different oxidation or valence states. The valence states of arsenic compounds relevant to human health are the trivalent (AsIII) and pentavalent (AsV) states. These arsenic species include arsenates (compounds containing AsO4 3–), arsenites (compounds containing AsO3 3–), and the monomethyl (MMA) and dimethyl (DMA) metabolites. Arsenic species in the trivalent state including arsenous acid (commonly arsenite), monomethylarsonous acid (MMAIII), and dimethylarsinous acid (DMAIII) are generally considered more toxic at lower doses than other arsenic species, although the complexity of arsenic species interconversion and the number of uncharacterized species casts uncertainty in adherance to this generalization.

5There are numerous other arsenic species, many of which we know little about. For example, fish and algae contain arsenobetaine (C5H11AsO2) as well as arsenoproteins, arsenolipids, and arsenosugars, many of which have not been characterized. Arsenobetaine is generally considered to be of low toxicity compared with some forms of inorganic arsenic. Some arsenosugars have been shown to be bioaccessible and metabolized in humans, and limited studies demonstrate toxicity in vitro. Because seafood can contain up to 100 times more total arsenic than rice does, and contains a variety of poorly understood organoarsenical compounds, researchers are calling for more detailed studies of these forms of arsenic. Thiolated arsenosugars have been identified as being generated in the human gut and readily absorbed by gut epithelium; toxicity studies are suggestive of adverse health effects but studies are sparse. In addition to toxicity differences, arsenic species can vary tremendously in terms of bioavailability, environmental fate, and transport characteristics, and remediation strategy effectiveness.

6Future arsenic research needs to expand our understanding of the variety of arsenicals that exist in the environment, better characterize more arsenic species (e.g., currently uncharacterized arsenoproteins, arsenosugars, and arsenolipids), understand their toxicokinetics in vivo in humans and rodents, and evaluate their fate and transport in the environment. Furthermore, rather than measuring only total arsenic, researchers are moving toward more frequently measuring specific arsenic species in environmental and human samples to gain a more complete and detailed understanding of arsenic exposures and health risks. Researchers are exploring ways to overcome challenges in human sample collection, sample handling variability, and the short half-life of some arsenic species in solution.

7Understanding arsenic exposure from diet. In some regions of the world including sites in the United States, arsenic exposures from drinking water are an urgent concern in the face of high concentrations of naturally occurring arsenic. Although exposure from drinking water remains a major concern, recent research reveals other sources of arsenic exposure. Identifying and characterizing these sources of arsenic exposure is very important for finding ways to minimize exposures and health risks.

8One non–drinking-water source of arsenic exposure that is of increasing concern is the diet. Arsenic is present in a wide variety of foods including fish and rice. Fish contain high amounts of organic arsenic compounds, predominantly arsenobetaine. In contrast, rice contains predominantly inorganic arsenic. The relative contribution of the diet as a source of arsenic exposure may be substantial, particularly when drinking-water arsenic levels are low. For example, one study modeled dietary exposure data that was collected in three U.S. population studies: National Human Exposure Assessment Survey (NHEXAS-AZ), Binational Exposure Assessment Survey (BAsES, Arizona population only), and National Health and Nutrition Examination Survey (NHANES). The authors estimated that diet contributed 54–85% of total inorganic arsenic intake for individuals whose tap water contained < 10 μg/L arsenic. A separate analysis of data from the NHEXAS-AZ and Arizona Border Survey population studies also suggests that dietary arsenic concentrations may be better predictors of urinary arsenic than drinking-water concentrations.

9It is challenging to quantify dietary exposure by measuring arsenic in foods. A duplicate diet study is one approach that uses direct measurements of duplicate samples of the foods that study participants consume over a period of time during the study. These types of studies are the most accurate because they account for individual variability in food samples due to factors such as food growing conditions, preparation methods, and modifications through processing. Although duplicate diet studies have been informative for assessing dietary arsenic exposure and estimating health risks, they are expensive to conduct.

10An indirect measure of arsenic in foods relies on databases that contain arsenic concentration measurements for a wide variety of food types, and then using these measurements to estimate exposure based on mean values from that data. For example, arsenic exposure from rice would be estimated based on the amount consumed and the average amount of arsenic in rice reported in these databases. One such database is the ongoing U.S. FDA (Food and Drug Administration) Total Diet Study that measures about 800 contaminants and nutrients in foods present in the average U.S. diet. There are a limited number of total diet studies that have measured arsenic in foods, and many of these studies measured only total arsenic concentrations. Furthermore, arsenic concentrations in multiple samples of the same food are highly variable, and as discussed above, making generalizations of arsenic content in a specific food can be quite difficult.

11One study compared measured urinary arsenic concentrations with modeled dietary exposure estimates based on two sets of dietary data: a) the results of a duplicate diet study that measured total arsenic in duplicate diet samples, water, and urine over a 24-hr period for 252 people in the NHEXAS-AZ and Arizona Border Survey studies; and b) a total diet study using 24-hr diaries that estimated average arsenic content in food items from several published food surveys. The researchers found that the total diet study greatly underestimated dietary arsenic intake and that the duplicate diet study more accurately reflected the amount ingested to urinary biomarkers of exposure. More research is needed to unravel the complexities of dietary arsenic exposure assessment in order to better understand this exposure pathway.

12Understanding arsenic exposure from dust, soil, and air. Arsenic exposure from dust, soil, and air should be better quantified and characterized, particularly near former mining sites, smelting sites, and industrial areas, including Superfund sites. A Superfund site is a location in the United States that has been contaminated with hazardous waste and identified as a priority site for cleanup by the U.S. EPA (Environmental Protection Agency) because it poses a significant risk to human health and/or the environment. The migration of arsenic from sediments and soils to groundwater sources and agricultural crops is not well understood and requires more research. For example, although a recent study in Cambodia reported that geochemical soil characteristics may be more predictive of arsenic content in rice crops than the concentrations of arsenic in water used for irrigation, it has also been shown that high arsenic concentrations in irrigation water can increase arsenic concentrations in rice and reduce rice crop yields. These types of exposure risks require better characterization, especially under special exposure scenarios such as populations who rely on rice for a large proportion of their diet and those who live near a Superfund site.

13Bioavailability is another important factor to consider in allocating exposure to different sources, and ongoing research is focusing on development of cost-effective methods to measure bioavailability. For example, only a portion of the total arsenic in soil is bioavailable, or able to be absorbed, by living organisms. Arsenic bioavailability has been measured directly using expensive in vivo animal feeding studies called relative bioavailability assays. Recently, a less expensive in vivo assay has been developed using a mouse model. Bioavailability has also been estimated using inexpensive in vitro bioaccessibility assays (IVBA) under conditions that mimic stomach and gastrointestinal environments, and several IVBA assays have demonstrated consistency in predicting bioavailability. One study performed extensive validity testing of 10 in vitro assays by comparing those results with swine in vivo assays using linear regression analysis, goodness of fit, variability in model bias and prediction error, and other parameters; validated studies had goodness-of-fit (R 2) values ranging from 0.59 to 0.71. Although promising, these in vitro assays need to be tested further using a wider variety of sample types and larger numbers of samples. Although bioavailability testing has focused primarily on soils, more research is also warranted for bioavailability assessment of other exposure media such as dust and foods.

14Assessing arsenic exposure is complex because arsenic is found in multiple forms and in multiple exposure media. The media themselves also are complex, containing other co-contaminants and microbes that can influence arsenic metabolism, bioavailability, and health effects. Aggregate exposure refers to the totality of all of these exposures and may better reflect actual exposure. For this reason, future research aims to more thoroughly identify and characterize arsenic content as well as co-contaminants such as cadmium and fluoride in exposure media. Furthermore, understanding dynamic influences of co-exposures on the bioavailability and toxicokinetics of arsenic is very important for understanding the relationship between external dose, internal dose, and health outcomes.

15Concentrations of arsenic and its metabolites in biological samples, such as urine, blood, toenails, and hair, are used as biomarkers of arsenic exposure. Although biomarkers are very important for exposure assessment, questions remain pertaining to the relationship between biomarkers and internal exposure. For example, variability in renal function and urinary creatinine levels add uncertainties to associations between urine arsenic concentrations and internal exposure; measuring arsenic in exfoliated urinary bladder epithelial cells may reduce some of these uncertainties. These biomarkers are generally understood to represent different time frames of exposure (e.g., urinary arsenic for acute and recent exposures, and toenail arsenic for exposures over several months). Researchers are increasingly measuring arsenic in toenails because these samples are less susceptible to variability in sample handling and easier to transport from the field to the laboratory. More recently, studies have shown associations between arsenic exposure and epigenetic modifications of specific genes, suggesting that epigenetic modifications may be useful as biomarkers of exposure.

16There are a plethora of studies linking specific biomarkers of exposure with health effects, but questions remain. New research needs to probe whether these biomarkers and exposure modeling estimates truly reflect internal exposures. For example, factors that modify arsenic metabolism in vivo (e.g., folate content in diet and the gut microbiome) may result in differences in metabolism and absorption, adding complexity to relationships between urinary arsenic levels and internal exposure estimates. Sample handling variability also introduces uncertainties in exposure estimates; some arsenic metabolites are more easily oxidized in urine than other metabolites. Urinary creatinine, conventionally thought of as a standard to normalize urine dilution between samples, may vary with arsenic-related kidney effects, age, and other factors; therefore, researchers have suggested using specific gravity to normalize for urine dilution.

17To address challenges in sample handling and environmental arsenic detection, researchers are developing systems that are more affordable and easy to use for field testing of samples. One example is a portable monitor for on-site measurement of arsenic species in urine samples that is being developed by Geiner Inc. (Dwiek B, personal communication; ). The system allows for rapid analysis of AsIII and AsV with sensitivity down to 1–5 parts per billion. Another promising approach uses a transcriptomics platform to screen for arsenic-induced gene expression in certain bacteria and fungi as sensors of arsenic in biological samples (Rosen B, personal communication; ). Once specific genes and organisms are identified, they may be useful as sensors in future rapid, portable testing systems. Exposure to arsenic also can occur indoors from dust, and a new passive sampler device provides a low-cost method for assessing indoor air exposure.

18More data are needed to understand relationships between exposures and biomarkers for a greater variety of exposure media and biological tissues. For example, changes in metabolomic profiles may be related to arsenic exposure and may be early indicators of adverse health effects. There is also a substantial need to develop guideline levels for chronic exposure in different media based on toenail arsenic concentrations. Toenail samples are increasingly used for biomonitoring because they are stable and relatively easy to collect, store, and transport. It is also very important to perform speciation analysis when assessing exposure in environmental or biological samples, and tools such as the novel assay and monitoring systems described above will facilitate collection of that data. A combination of urine concentrations (measured over time), toenail concentrations, external exposure measurements, and probabilistic modeling based on intake source concentrations (e.g., diet) may be the best approach to measure aggregate exposure.

19Elucidating arsenic-related health outcomes from environmental exposure is confounded by co-exposure to other agents such as lead, cadmium, fluoride, polyaromatic hydrocarbons, and pesticides. For example, groundwater with high concentrations of arsenic often naturally contains high concentrations of fluoride. Exposure to high levels of fluoride over long periods of time has been shown to affect bone health and other organ systems in the body. Some studies have shown that co-exposure of arsenic and fluoride can be synergistic or antagonistic, depending on the outcome being assessed. One study in mice demonstrated reduced oxidative stress in liver and kidney when arsenic and fluoride were administered together compared with each alone. Another study in rats found learning and memory was impaired whether exposed to both arsenic and fluoride together or separately. However, exposure to arsenic and fluoride together resulted in a more stubstantial decrease in gluatamate receptor 5 (mGluR5) mRNA expression in the cortex and mGluR5 protein expression in the hippocampus than when rats were exposed to arsenic alone; fluoride exposure alone had no significant effect on these parameters. More studies are clearly needed to better understand possible effects of co-exposures. It is clear that co-exposure to fluoride and other contaminants is an important factor to consider in epidemiological studies of arsenic-related toxicity.

20The microbiome, particularly within the digestive tract, plays an active role in health and disease. Recent studies have been exploring relationships between the gut microbiome and arsenic exposure, metabolism, and toxicity. One recent study demonstrated that arsenic exposure of mice at environmentally relevant doses (10 mg/L in drinking water) changed the types of microbes present in the gut as well as the global metabolomic profile of those microbes. In fact, about 400 microbial metabolic changes were noted in feces of the exposed mice. Also, arsenic metabolite profiles in mice changed when the gut microbiome was altered by infection or in the absence of interleukin (IL)-10 in the host. Microbes from the human gut have been shown to generate thiolated arsenic metabolites, and the toxicity of these metabolites is not well characterized.

21Together these data demonstrate potential influences of the microbiome on arsenic metabolism, as well as arsenic effects on microbiome composition and metabolism. These factors can influence the relationship between arsenic concentrations in the environment (e.g., drinking water and food) and the eventual internal arsenic body burden because the gut microbiome affects the relationship between these environments (external and internal). It is also theoretically possible that variations in microbiome composition between individuals may contribute to differences in individual susceptibility by influencing arsenic metabolite profiles. Clearly more research is needed to further characterize microbes that affect arsenic metabolism, arsenic effects on the microbiome, and links between changes in the microbiome and arsenic-associated disease outcomes.

22Given that arsenic is present in multiple media—food, water, soil, air, and dust—any individual is likely to have multiple routes and media of exposure. This scenario creates a substantial challenge for estimating exposure. Fate and transport, simulation, and probabilistic modeling are some approaches that can be used in conjunction with sampling measurement to estimate aggregate exposure. These types of analyses, such as using soil sample concentrations to predict exposure and estimate health risks, are useful for risk assessment at specific sites. Also, some aggregate exposure modeling studies have used a multi-media, multi-pathway exposure assessment and identified house dust as an important source of exposure in mining communities.To develop a stronger foundation of data for future modeling studies, workshop participant indicated that duplicate diet studies, more sampling of food and other media, and more speciation data in all exposure media are needed to develop a stronger foundation of data for future modeling studies.

23Prevention strategies to reduce exposure to arsenic from drinking water will need to address the problem from different perspectives. Strategies should consider local sources of exposure, intended use of the water supply, and the local capacity to implement the preventative strategies. There are numerous approaches to remediation of arsenic in groundwater and drinking water. Sustainable, resilient exposure prevention strategies at the local level need to account for existing community capacity and cultural norms that may affect understanding and implementation of the strategies. For example, point-of-use filters eventually filter water more slowly over time, causing people to be less likely to use them. Furthermore replacement filters are costly (Gamble M, personal communication; ).

24At the community level, exposure prevention requires identification of contaminated sources, notification of the problem to the community, and education to persuade people to use safer water sources. Municipal water supplies are monitored for arsenic by state or local agencies, but private wells are not. To identify local sources of exposure, particularly drinking-water wells, real-time–sensitive and affordable field detection methods that are accessible to communities are crucial. Furthermore, reliable methods that can result in greater community awareness are essential for publicizing the identity of high- and low-arsenic water sources.

25However, community awareness alone is not sufficient to affect behavior. One study of 386 households in central Maine surveyed homeowners who were notified that their well water contained > 10 μg/L arsenic 3–7 years before the study. Even knowing that their water contained high arsenic concentrations, 27% of households continued to use the well water. In contrast, educating Bangladeshi elementary school children about health risks from arsenic exposure resulted in five times more families switching to cleaner wells compared with families whose children did not receive the education. The disparate responses point to the need for more research on factors that foster the use of prevention strategies as the best technology has no value if people do not use it.

26The diet is an important source of arsenic exposure, and is garnering more attention as researchers seek to identify and quantify arsenic in foods. One notable food source of arsenic is rice. Given that more than half of the world’s population relies on rice for a substantial portion of their daily diet, it becomes essential to reduce the arsenic content of rice. One possible strategy to modify the amount of arsenic in rice plants uses plant biology and genetics. For example, studies showed that growing rice in flooded paddies made arsenic more bioavailable to rice plants than for those grown under conditions without flooding, but unflooded conditions resulted in increased cadmium uptake by the rice plant. Other studies reported variation in arsenic uptake between different rice cultivars and genotypes; growing cultivars that have low arsenic uptake could potentially be a simple and cost-effective method for exposure reduction. Researchers are also using genome-wide association studies (GWAS) to identify plant genes that play a role in arsenic accumulation toward the goal of manipulating that process, either increasing absorption for soil remediation or decreasing absorption for food-source plants.

27Levels of arsenic in the irrigation water can also be reduced using a variety of strategies. Irrigation channel dimension, water flow rate, and soil and water chemistry can all affect the effectiveness of arsenic removal from flowing irrigation water. Several workshop participants suggested consideration of arsenic water standards set at different levels depending on intended use. For example, drinking-water standards may be more stringent than crop irrigation–water standards and yet still be protective of public health. Setting such use-specific standards requires more research to quantify exposure parameters. For irrigation-water standards, risk assessments would need to take into account plant uptake of arsenic that can vary depending on the crops and how they are grown. Another mitigation strategy is filtering irrigation water, as is currently used for some vineyards in Northern California.

28Soil and dust can be significant pathways of exposure, particularly near mining or smelting sites. There are a number of different approaches to remediation of arsenic in soils and dust, as well as daily-living exposure-reduction strategies such as hand and food washing.

29One example of a cost-effective and sustainable method to stabilize outdoor soils and dusts is phytostabilization. The goal of phytostabilization is to identify plants that could serve as permanent vegetative cover and, over time, may stabilize arsenic in the soil in a mineral form with low bioavailability. Stabilization may also reduce dispersal of contaminated dust. An ongoing study in Arizona is field testing several plants and optimizing growing conditions to maximize stabilization of arsenic-contaminated dust near a former smelting site. Recently, oxidized arsenic was co-localized with Actinobacteria on plant root surfaces using state-of-the-art microscopic visualization with resolution down to the 2-μm scale (Maier R, personal communication; ). Actinobacteria are known to oxidize arsenic and to be resistant to metal toxicity, so their oxidizing capability combined with phytostabilization by the plants may provide powerful tools to reduce exposures from contaminated soils and dust; however, greater understanding of the relationships between these bacteria and the phytostabilizing plants is needed.

30Mechanisms of response and biomarkers of susceptibility to arsenic are interrelated. Biomarkers can help researchers identify associated pathways and disease mechanisms. Understanding disease mechanisms can uncover new biomarkers of pathogenesis or disease precursors that may then be used to assess susceptibility in early life stages for later disease. Key data gaps lie in the links among life stage, exposure level, early effects, and later disease. Future research directions are aiming to integrate biomolecular and epidemiological data with susceptibility and health outcomes.

31Emerging research on epigenetic changes following exposure to arsenic is focusing on identifying biomarkers of exposure, response, disease, and susceptibility and elucidating disease mechanisms. Researchers search for epigenetic changes, and hone in on loci for which the change is likely to alter gene expression. Researchers can then use a bottom-up approach to determine whether epigenetic changes for a specific gene has downstream effects on protein expression and ultimately affects the physiological response to arsenic. Identifying these pathways could in turn lead to identification of arsenic-associated health outcomes that otherwise might have been difficult to associate with arsenic exposure.

32Studies are beginning to connect epigenetic changes to specific health outcomes. One study of a pregnancy cohort in Mexico screened > 400,000 CpG sites for methylation changes in 38 cord blood samples. Drinking-water concentrations for this study population were 0.456–236 μg/L. They focused on 16 genes with arsenic-associated changes in methylation that also demonstrated changes in gene expression. DNA methylation levels for 7 of the 16 genes were associated with differences in gestational age and head circumference. The 16 genes are enriched for binding sites of specific transcription factors that have been shown to be altered by arsenic exposure and affect cellular signaling pathways.

33Researchers are also working to characterize epigenetic changes in more defined cell populations and tissues. Blood and other tissues consist of a mixture of cell types, and different cell types might have distinct epigenetic changes. For example, one study used specific differentially methylated regions (DMRs) as tags to identify specific types of blood cells in cord blood. Using this technique to identify different cell subtypes, researchers examined the association between DNA methylation in cord blood and arsenic exposure via drinking water for a Bangladeshi pregnancy cohort. They found that arsenic exposure was associated with a significantly increased percentage of CD8+ lymphocytes and a decreased percentage of CD4+ lymphocytes. Furthermore, using the DMRs, they adjusted for the altered cell type distribution for DNA methylation analysis, and identified altered DNA methylation patterns that were associated with arsenic exposure.

34More in-depth research into epigenomic, transcriptomic, and proteomic changes are needed to link changes in DNA methylation and gene expression to health outcomes. Studies need to include different lifestages, tissues, and organs as well as comparsions of response pathways at high and low doses of arsenic. Last, follow-through on linking omics data to health effects should include mechanistic studies to validate arsenic-mediated mechanisms of response.

35There is ample evidence demonstrating that some individuals are more susceptible to arsenic than others. For example, exposure during early life is associated with increased risk of adverse effects that can persist into adulthood. One of the more striking examples is the nearly 50-fold increased standardized mortality ratio for bronchiectasis in a population of young adults in Chile who were exposed to high levels of arsenic from drinking water in utero and during childhood; mortality rates for this group were compared with mortality rates for the rest of the Chilean population. Genetic factors can also play a role in susceptibility, as demonstrated for AS3MT polymorphisms. As new biomarkers and factors of susceptibility are identified, as discussed above, researchers need to use that information to inform understanding of mechanisms of life stage and population susceptibility. Research is turning toward defining molecular mechanisms for these effects as well as biomarkers for susceptibility to disease in adulthood. Such diseases might be prevented or reduced through intervention in earlier life stages for susceptible individuals.

36To better identify susceptible populations, susceptibility factors need to be investigated at the population level. For example, are analyzing AS3MT polymorphisms at the population level. In this study, several single nucleotide polymorphisms associated with lower urinary percent MMA occur at much higher frequency in an Argentinian Andes population living in a region where elevated arsenic levels in drinking water is common, compared with Peruvian and Colombian populations living in regions with lower arsenic level in drinking water. These data suggest the possibility of a population adaptation to tolerate arsenic as an environmental stressor, and identify gene variants of the AS3MT gene associated with reduced risks. Characterization of these variants may inform strategies to minimize health effects from arsenic exposure. For example, protective variants might reveal proteins and pathways that have potential to prevent or reduce adverse arsenic-related health outcomes. Expanding on these types of studies, more large-scale genotyping of the AS3MT gene and other arsenic response-related genes is needed to better assess and quantitate population risks.

37Clearly many factors—genetic and environmental—play a role in the response to arsenic exposure, and these factors can have various impacts in different life stages and different individuals. We are only beginning to understand how arsenic affects these processes across the life span. For example, epigenetic regulation plays an essential role in normal development whereby genes are turned on and off in sequence, and such changes are often heritable during cell division. Therefore, arsenic-associated epigenetic changes during early life may have long-term consequences. As research more clearly defines susceptibility factors, it is important to analyze those factors across populations and lifestages, and ultimately to use such information to quantitatively assess risk. The integration of molecular-level studies with in vivo animal and epidemiological studies is very important to delineate the importance of various susceptibility factors and identify new ones.

38Recent information about dietary exposures, newly identified health outcomes, and susceptibility factors and biomarkers provides new factors to consider in health risk assessments and risk mitigation strategies. A large number of existing data are being re-evaluated in the context of quantitative risk, but substantial data gaps remain.

39Workshop participants discussed identification of key susceptibility factors that need to be evaluated in the context of risk assessment: genetics, metabolism, age, diet, and co-exposures to other agents. Research is needed on quantitation of risk with a goal of including quantifiable parameters in risk assessments. More human and rodent studies that include biomonitoring should measure arsenic species, particularly in biological samples. The percentage of MMA in urine, for example, holds promise as a quantifiable marker of risk. We may then better explore possible links between percent MMA, genetic polymorphisms, and health outcomes, with the ultimate goal of linking genetic polymorphisms to quantifiable risk. More studies of humans over time are needed to better understand life stage–related risks, most especially in early life. More studies on co-exposures (e.g., metals, smoking, pesticides, asbestos, silica) could shed light on possible synergistic effects. Last, critical evaluation and new studies of arsenic effects across the full dose range, including low-dose exposure, are needed, particularly in light of new information about susceptibility biomarkers and factors.

40Recent information about arsenic metabolic pathways and nutritional factors sheds light on the potential to use dietary changes to prevent or reduce arsenic-associated health effects. For example, researchers are focusing on the one-carbon metabolic pathway that is catalyzed by AS3MT and other enzymes, and converts arsenic into a variety of methylated species with varying toxicities. The goal is to find nutritional supplements or dietary changes that might prevent or mitigate arsenic toxicity. Researchers are now linking nutritional biochemistry studies with epidemiology to explore whether nutritional status and supplements may affect health outcomes stemming from arsenic exposure.

41Several epidemiology studies give credence to this possibility. In a Bangladeshi population, blood selenium levels were inversely associated with urinary arsenic concentrations. In another Bangladeshi population, blood levels of folate, which is used in the one-carbon metabolic pathway, were associated with arsenic methylation status in urine. Other studies suggest that B12, choline, homocysteine, betaine, and creatine levels may also be associated with changes in the arsenic metabolite profile in humans and in rats. Researchers are also studying whether nutritional supplementation can prevent or ameliorate arsenic-related health outcomes. For example, the Bangladesh Vitamin E and Selenium Trial (BEST) is a population-based, double-blind, randomized controlled trial of 7,000 adults with skin lesions that is designed to test supplementation for the prevention of nonmelanoma skin cancer. More research is needed to better understand the balance of nutritional influences because some nutrients at certain doses may increase arsenic toxicity, as suggested for high levels of selenium.

42Diet may negatively affect arsenic-associated effects on fat metabolism and liver function. Previous work has shown that arsenic exposure is associated with high cholesterol, liver inflammation, and liver steatosis. Co-exposure to a high-fat Western diet and arsenic in mice exacerbated the effects of a high-fat diet on the liver (e.g., increased size and steatosis), resulting in degeneration that was more severe and widespread than in the controls without arsenic exposure. Mice exposed to arsenic in utero were affected more strongly than mice exposed later in life. Arsenic also altered the lipid metabolic product profile in a pattern that suggests disruption in the tricarboxylic acid (TCA) cycle and increased ketogenesis. Together the data suggest that the metabolism of arsenic and fatty acids are intertwined, and can impact health outcomes.

43The one-carbon and TCA metabolic pathways are parts of a complex interwoven biochemical network with other biochemical pathways, and the complexity makes it difficult to predict how specific nutrients may change arsenic metabolism. Furthermore, many nutrients may affect arsenic metabolism and toxicity. A new mathematical model of arsenic metabolism has been developed to help make such predictions, and the model performed well in comparisons with epidemiological data. This model can be used to predict nutritional influences on arsenic metabolism before conducting in vivo testing.

44More data are needed to define nutritional changes and supplements that may prevent or minimize health effects. Nutritional status should be considered in epidemiological studies as a possible contributing factor to the outcomes of arsenic exposure, and collecting more data on nutrients and arsenic species in biological samples could enhance our understanding of these relationships. Because of the intricate interweaving of these biochemical pathways, it is difficult to predict how supplementation will affect the entire system. Nonetheless, nutritional supplementation holds potential as a cost-effective and practical approach to reducing health impacts of arsenic exposure.

45This review encompasses a number of promising research findings and future research directions related to the identification and reduction of arsenic exposures and health effects (Appendix 1). Key efforts are moving toward more detailed human aggregate exposure assessments that will require gathering information about the identification, sources, and biomonitoring of different arsenic compounds and species. The integration of technologies from multiple disciplines will be indispensable as researchers determine the complex mechanisms and develop strategies for preventing or mitigating arsenic exposure and consequent adverse health effects. A major challenge is to coalesce various data sets (e.g., omics with epidemiological and aggregate exposure data) to determine which variables are associated with the detrimental health outcomes of arsenic exposure. Finally, emerging biomarkers of arsenic exposure, effect, and susceptibility have the potential to be powerful tools for quantitative risk assessment and identification of susceptible populations and lifestages.

46Assessing non-drinking-water sources of exposure, particularly diet

47Characterizing toxicokinetics and bioavailability for more arsenic species (e.g., arsenosugars, arsenolipids, arsenoproteins)

48Developing accurate and portable field testing kits for arsenic that address the challenges in sample handling and environmental arsenic detection

49Understanding relationships between biomarkers and internal exposure

50Understanding relationships between biomarkers and exposures for a greater variety of exposure media and biological tissues

51Elucidating possible health effects of co-exposure to other agents such and lead, cadmium, and fluoride

52Studying effects of arsenic on the microbiome, and effects of the microbiome on arsenic metabolism and internal exposure

53Developing approaches to estimate aggregate exposure from multiple media and multiple pathways

54Improving remediation strategies at the local level

55Developing strategies to effect behavioral change for individuals to take action to reduce exposures

56Finding effective ways to reduce dietary exposures, particularly in rice

57Creating effective strategies to minimize arsenic exposure from soil and dust near Superfund sites

58Using omics technologies to identify biomarkers linking exposure to susceptibility, disease onset, and long-term disease

59Conducting molecular epidemiology studies

60Identifying susceptible populations (e.g., life stage, genetic factors)

61Finding approaches for quantitating risks for use in risk assessments

62Exploring influences of nutrition on arsenic susceptibility and health risk reduction